157 related articles for article (PubMed ID: 23568816)
1. Long-term adaptation of Saccharomyces cerevisiae to the burden of recombinant insulin production.
Kazemi Seresht A; Cruz AL; de Hulster E; Hebly M; Palmqvist EA; van Gulik W; Daran JM; Pronk J; Olsson L
Biotechnol Bioeng; 2013 Oct; 110(10):2749-63. PubMed ID: 23568816
[TBL] [Abstract][Full Text] [Related]
2. The challenge of improved secretory production of active pharmaceutical ingredients in Saccharomyces cerevisiae: a case study on human insulin analogs.
Kazemi Seresht A; Palmqvist EA; Schluckebier G; Pettersson I; Olsson L
Biotechnol Bioeng; 2013 Oct; 110(10):2764-74. PubMed ID: 23592021
[TBL] [Abstract][Full Text] [Related]
3. Changes in the metabolome of Saccharomyces cerevisiae associated with evolution in aerobic glucose-limited chemostats.
Mashego MR; Jansen ML; Vinke JL; van Gulik WM; Heijnen JJ
FEMS Yeast Res; 2005 Feb; 5(4-5):419-30. PubMed ID: 15691747
[TBL] [Abstract][Full Text] [Related]
4. Understanding the metabolic burden of recombinant antibody production in Saccharomyces cerevisiae using a quantitative metabolomics approach.
de Ruijter JC; Koskela EV; Nandania J; Frey AD; Velagapudi V
Yeast; 2018 Apr; 35(4):331-341. PubMed ID: 29159981
[TBL] [Abstract][Full Text] [Related]
5. Metabolic analysis of the synthesis of high levels of intracellular human SOD in Saccharomyces cerevisiae rhSOD 2060 411 SGA122.
Gonzalez R; Andrews BA; Molitor J; Asenjo JA
Biotechnol Bioeng; 2003 Apr; 82(2):152-69. PubMed ID: 12584757
[TBL] [Abstract][Full Text] [Related]
6. Growth-rate dependency of de novo resveratrol production in chemostat cultures of an engineered Saccharomyces cerevisiae strain.
Vos T; de la Torre Cortés P; van Gulik WM; Pronk JT; Daran-Lapujade P
Microb Cell Fact; 2015 Sep; 14():133. PubMed ID: 26369953
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Phenotypically Distinct Subpopulations Is a Factor in Adaptation of Recombinant Saccharomyces cerevisiae under Glucose-Limited Conditions.
Wright NR; Jessop-Fabre MM; Sánchez BJ; Wulff T; Workman CT; Rønnest NP; Sonnenschein N
Appl Environ Microbiol; 2022 Apr; 88(7):e0230721. PubMed ID: 35297727
[TBL] [Abstract][Full Text] [Related]
8. Multi-omic profiling -of EPO-producing Chinese hamster ovary cell panel reveals metabolic adaptation to heterologous protein production.
Ley D; Seresht AK; Engmark M; Magdenoska O; Nielsen KF; Kildegaard HF; Andersen MR
Biotechnol Bioeng; 2015 Nov; 112(11):2373-87. PubMed ID: 25995028
[TBL] [Abstract][Full Text] [Related]
9. Engineering cellular redox balance in Saccharomyces cerevisiae for improved production of L-lactic acid.
Lee JY; Kang CD; Lee SH; Park YK; Cho KM
Biotechnol Bioeng; 2015 Apr; 112(4):751-8. PubMed ID: 25363674
[TBL] [Abstract][Full Text] [Related]
10. The metabolic burden of cellulase expression by recombinant Saccharomyces cerevisiae Y294 in aerobic batch culture.
van Rensburg E; den Haan R; Smith J; van Zyl WH; Görgens JF
Appl Microbiol Biotechnol; 2012 Oct; 96(1):197-209. PubMed ID: 22526794
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of central metabolite pools to variations in growth rate and cultivation conditions in Saccharomyces cerevisiae.
Kumar K; Venkatraman V; Bruheim P
Microb Cell Fact; 2021 Mar; 20(1):64. PubMed ID: 33750414
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three expression systems for heterologous xylanase production by S. cerevisiae in defined medium.
Görgens JF; Planas J; van Zyl WH; Knoetze JH; Hahn-Hägerdal B
Yeast; 2004 Oct; 21(14):1205-17. PubMed ID: 15515128
[TBL] [Abstract][Full Text] [Related]
13. Fluctuations in glucose availability prevent global proteome changes and physiological transition during prolonged chemostat cultivations of Saccharomyces cerevisiae.
Wright NR; Wulff T; Palmqvist EA; Jørgensen TR; Workman CT; Sonnenschein N; Rønnest NP; Herrgård MJ
Biotechnol Bioeng; 2020 Jul; 117(7):2074-2088. PubMed ID: 32277712
[TBL] [Abstract][Full Text] [Related]
14. Prolonged selection in aerobic, glucose-limited chemostat cultures of Saccharomyces cerevisiae causes a partial loss of glycolytic capacity.
Jansen MLA; Diderich JA; Mashego M; Hassane A; de Winde JH; Daran-Lapujade P; Pronk JT
Microbiology (Reading); 2005 May; 151(Pt 5):1657-1669. PubMed ID: 15870473
[TBL] [Abstract][Full Text] [Related]
15. In vivo kinetics of primary metabolism in Saccharomyces cerevisiae studied through prolonged chemostat cultivation.
Wu L; Mashego MR; Proell AM; Vinke JL; Ras C; van Dam J; van Winden WA; van Gulik WM; Heijnen JJ
Metab Eng; 2006 Mar; 8(2):160-71. PubMed ID: 16233984
[TBL] [Abstract][Full Text] [Related]
16. Chemostat-based micro-array analysis in baker's yeast.
Daran-Lapujade P; Daran JM; van Maris AJ; de Winde JH; Pronk JT
Adv Microb Physiol; 2009; 54():257-311. PubMed ID: 18929070
[TBL] [Abstract][Full Text] [Related]
17. Central carbon metabolism of Saccharomyces cerevisiae in anaerobic, oxygen-limited and fully aerobic steady-state conditions and following a shift to anaerobic conditions.
Wiebe MG; Rintala E; Tamminen A; Simolin H; Salusjärvi L; Toivari M; Kokkonen JT; Kiuru J; Ketola RA; Jouhten P; Huuskonen A; Maaheimo H; Ruohonen L; Penttilä M
FEMS Yeast Res; 2008 Feb; 8(1):140-54. PubMed ID: 17425669
[TBL] [Abstract][Full Text] [Related]
18. Amino acid supplementation improves heterologous protein production by Saccharomyces cerevisiae in defined medium.
Görgens JF; van Zyl WH; Knoetze JH; Hahn-Hägerdal B
Appl Microbiol Biotechnol; 2005 Jun; 67(5):684-91. PubMed ID: 15630584
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of control mechanisms for Saccharomyces cerevisiae central metabolic reactions using metabolome data of eight single-gene deletion mutants.
Shirai T; Matsuda F; Okamoto M; Kondo A
Appl Microbiol Biotechnol; 2013 Apr; 97(8):3569-77. PubMed ID: 23224404
[TBL] [Abstract][Full Text] [Related]
20. Gcn4p and the Crabtree effect of yeast: drawing the causal model of the Crabtree effect in Saccharomyces cerevisiae and explaining evolutionary trade-offs of adaptation to galactose through systems biology.
Martínez JL; Bordel S; Hong KK; Nielsen J
FEMS Yeast Res; 2014 Jun; 14(4):654-62. PubMed ID: 24655306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
